Simplifying HT Nucleic Acid Purification with Expert Automation Support
Topics covered include:
- An overview of purification options for every scale
- Common barriers to automating and examples of solutions developed by the Promega support team
- Q&A to address submitted questions
Summary
Does the thought of implementing high throughput (HT) processes intimidate you or cause you stress? Are you ready to embark on automating your nucleic acid purification workflow? Do you need help making changes to your existing workflow? Maybe you haven't considered automation, but are experiencing growing pains in your lab related to your current workflow? Perhaps you have had some experience automating certain workflows but the task at hand sounds daunting and there are too many unknowns that make you want to rethink automation altogether? There are many options to choose from and adoption can seem like an insurmountable obstacle.
Join Bats Mutamba, Field Support Scientist, for an overview of HT nucleic acid purification options, common implementation barriers and examples of custom solutions. You will also learn how our custom HT purification support can help you avoid stress and save time, providing you with peace of mind and the opportunity to work on other urgent, high priority, or intellectually stimulating projects. Our team will be available throughout the presentation and during the live Q&A that follows to answer any questions you might have about automating your nucleic acid purification workflow.
Speaker
Bats Mutamba
Field Support Scientist
Promega Corporation
Bats Mutamba, a Field Support Automation Scientist with over 14 years of automation experience, was born and raised in Zimbabwe with a background in microbiology, biochemistry and biotechnology from Rhodes University, South Africa. He moved to the US where he completed a Masters in Cellular and Molecular Nutrition from UNC Greensboro and later worked for Duke University Medical Center as a Research Analyst in the Department of Pharmacology and Biochemistry. Later in his career, Bats worked as a senior scientist responsible for the development and validation of various assays utilizing automated liquid handlers. He also has experience developing and automating lab developed tests (LDTs) for early detection and diagnosis of several cancers.